Alto Neuroscience
Assets
image
NYSE opening bell podium, IPO day
2024-02-02
image
NYSE trading floor with Alto branding
2024-02-02
patent
Patent US 2025/0120957 A1 — Treatment of neuropsychiatric disorders with tilivapram
2025-04-17
poster
Poster, SOBP 2025 — Translational utility of ERP and time-frequency features for CIAS: preclinical evaluation of MK-801 deficits and rescue by ALTO-101
2025-04
poster
Poster, SOBP 2025 — Gamma band EEG sample entropy, a patient selection biomarker for ALTO-300, is increased by dopamine depletion in humans and mice
2025-04